Side A · Liner notes
STAT+: Roche continues to look to China for new drugs
Nutrition · Words by Elaine Chen and Jonathan Wosen · Released
China's Hansoh Pharmaceutical Group has announced that it struck a massive deal with Roche to develop a portfolio of antibody-drug conjugates.
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Good morning. I haven’t yet watched the new Elizabeth Holmes documentary, so I haven’t yet read this review by Theranos whistleblower Tyler Schultz (since it contains spoilers). But if you’ve seen the movie, go ahead and read the review (and don’t spoil anything for me).
Roche continues to look to China for new drugs
China’s Hansoh Pharmaceutical Group said yesterday it struck a massive deal with Roche to develop a portfolio of antibody-drug conjugates.
